# Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique

> **NCT05362682** · — · UNKNOWN · sponsor: **International Vaccine Institute** · enrollment: 3000 (estimated)

## Conditions studied

- Sars-CoV-2 Infection

## Interventions

- **OTHER:** Sinopharm Vaccine

## Key facts

- **NCT ID:** NCT05362682
- **Lead sponsor:** International Vaccine Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-24
- **Primary completion:** 2024-02-28
- **Final completion:** 2024-08-30
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2023-04-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05362682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05362682, "Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05362682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*